• Idoxuridine: Mechanistic Insights and Evolving Roles in Anti

  2026-06-18

  Explore the advanced mechanistic understanding of Idoxuridine as a viral DNA synthesis inhibitor. This in-depth article reveals novel research perspectives and practical assay implications, distinguishing itself from conventional protocol guides.

• Jasplakinolide: The Gold Standard Actin Polymerization Induc

  2026-06-18

  Jasplakinolide is redefining actin cytoskeleton research with its high-affinity, membrane-permeable properties, enabling precise manipulation of actin dynamics for functional genomics, cytotoxicity, and antifungal studies. This guide offers workflow enhancements, comparative advantages, and troubleshooting strategies that empower bench scientists to maximize experimental reproducibility and interpretability.

• Radicicol: Deep Mechanistic Insights & Protocols for Transla

  2026-06-17

  Explore Radicicol as an advanced Hsp90 inhibitor for apoptosis and inflammation research. Uncover deeper mechanistic insights, assay guidance, and translational relevance not found in standard reviews.

• Protein A/G Magnetic Beads: Practical Guidance for Immunopre

  2026-06-17

  Protein A/G Magnetic Beads are designed for high-specificity purification of IgG antibodies and protein interaction studies from complex biological samples. These beads minimize non-specific binding in applications such as immunoprecipitation, co-IP, and Ch-IP. They are not suitable for diagnostic or medical use and should not be employed for applications requiring binding of non-IgG classes.

• WM-8014: Selective KAT6A Inhibitor for Epigenetic Research

  2026-06-16

  WM-8014 is a reversible, highly selective KAT6A inhibitor that induces cell cycle arrest and oncogene-induced senescence without broad cytotoxicity. Its competitive acetyl-CoA site binding enables precise modulation of epigenetic targets in cancer biology research. WM-8014 is validated by robust in vitro and in vivo models for non-cytotoxic pathway interrogation.

• Gap19: Selective Connexin 43 Hemichannel Blocker for Neuropr

  2026-06-16

  Gap19 offers researchers an unprecedented level of specificity for targeting Cx43 hemichannels without disrupting gap junctions, enabling robust and reproducible neuroprotection and inflammation studies. Its validated selectivity and performance unlock new experimental designs in stroke, astrocyte signaling, and macrophage polarization workflows.

• BGJ398 (NVP-BGJ398): Precision FGFR2/3 Inhibition in Oncolog

  2026-06-15

  Explore how BGJ398 (NVP-BGJ398) revolutionizes FGFR-driven malignancies research through highly selective inhibition of FGFR1, FGFR2, and FGFR3. This article delivers an advanced, practical perspective for oncology researchers, integrating the latest developmental biology insights and protocol guidance.

• Targeting SIA-cIgG/PTPN13 Improves Cisplatin Response in HNS

  2026-06-15

  This study reveals that SIA-cIgG expression drives chemoresistance and tumor stemness in head and neck squamous cell carcinoma (HNSCC) via the PTPN13 axis. Blocking SIA-cIgG enhances cisplatin efficacy, offering a promising molecular target for overcoming chemotherapy resistance in HNSCC.

• Thiamet G: O-GlcNAcase Inhibitor Workflows for Cellular Mode

  2026-06-14

  Thiamet G empowers researchers to elevate O-GlcNAc levels with precision, enabling robust interrogation of tau phosphorylation, leukemia sensitization, and preeclampsia pathways. This article details stepwise protocols, data-driven optimization, and actionable troubleshooting, while translating recent breakthroughs in O-GlcNAc biology into practical experimental insight.

• Pharmacokinetics of Corydalis saxicola Alkaloids in MASH Mod

  2026-06-13

  This study investigates how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids in mice. Through integrated analyses of drug metabolism and transporter expression, the research reveals that pathological liver conditions significantly increase systemic and hepatic exposure to key alkaloids, informing dose rationalization for MASLD/MASH treatment.

• E-4031 in Cardiac Electrophysiology: hERG Blocker in 3D Orga

  2026-06-12

  E-4031, a potent hERG potassium channel blocker, is revolutionizing cardiac electrophysiology by enabling precise modeling of proarrhythmic substrates and QT interval prolongation in advanced 3D organoid platforms. Discover experimental workflows, troubleshooting strategies, and cutting-edge applications empowered by APExBIO’s E-4031.

• Arachidonic Acid Supplementation Enhances Vaccine-Induced Im

  2026-06-12

  A recent study demonstrates that dietary arachidonic acid (ARA) supplementation accelerates and amplifies humoral immune responses to rabies vaccination in mice and humans. Mechanistically, ARA enrichment in lymph nodes and its metabolite-driven B cell activation underpin this enhanced immunity, suggesting a new avenue for dietary adjuvant strategies in vaccine optimization.

• Biotin-XX Tyramide Reagent: Precision Cell Surface Labeling

  2026-06-11

  Biotin-XX Tyramide Reagent empowers researchers to achieve ultra-selective, membrane-impermeant cell surface protein labeling with exceptional sensitivity. By leveraging its unique long-linker chemistry and proven proximity labeling workflow, users can decode complex cell-cell interactions and amplify low-abundance signals in spatial proteomics and histology.

• Sodium Oxamate in Cancer Metabolism: Protocols & Innovations

  2026-06-11

  Sodium Oxamate is transforming cancer metabolism research by targeting glycolytic reprogramming and lactate production. This article delivers stepwise protocols, advanced applications, and troubleshooting strategies, all grounded in the latest mechanistic studies and translational breakthroughs.

• Green Spectrophotometric Quantification of Alfuzosin HCl Mix

  2026-06-10

  Alqahtani et al. present the first validated spectrophotometric methods for quantifying Alfuzosin HCl and tadalafil in binary pharmaceutical mixtures, overcoming spectral overlap with absorbance subtraction and ratio difference approaches. This work streamlines the analysis of fixed-dose BPH therapies, providing an accessible, eco-friendly alternative to chromatographic techniques.

449 records 14/30 page Previous Next First page 上5页 1112131415 下5页 Last page